Chad Messer
Stock Analyst at Lake Street
(0.83)
# 3,973
Out of 5,044 analysts
29
Total ratings
44.83%
Success rate
-15.01%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Chad Messer
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GNLX Genelux | Initiates: Buy | $16 | $7.64 | +109.42% | 1 | Oct 21, 2025 | |
| MNPR Monopar Therapeutics | Initiates: Buy | $106 | $79.92 | +32.63% | 1 | Sep 23, 2025 | |
| BOLT Bolt Biotherapeutics | Maintains: Buy | $4 → $75 | $5.72 | +1,211.19% | 2 | Aug 15, 2025 | |
| ONCY Oncolytics Biotech | Initiates: Buy | $7 | $1.22 | +473.77% | 1 | Aug 13, 2025 | |
| COYA Coya Therapeutics | Initiates: Buy | $16 | $6.66 | +140.24% | 1 | Jul 9, 2025 | |
| LTRN Lantern Pharma | Initiates: Buy | $25 | $3.98 | +528.14% | 1 | Apr 2, 2025 | |
| IMNM Immunome | Initiates: Buy | $23 | $16.39 | +40.33% | 1 | Apr 2, 2025 | |
| OSTX OS Therapies | Initiates: Buy | $19 | $1.87 | +916.04% | 1 | Apr 2, 2025 | |
| ESPR Esperion Therapeutics | Maintains: Strong Buy | $134 → $114 | $3.04 | +3,650.00% | 3 | Aug 3, 2021 | |
| CELC Celcuity | Initiates: Buy | $50 | $74.44 | -32.83% | 1 | Jul 27, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $33 → $48 | $61.97 | -22.54% | 2 | Jul 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $33 → $30 | $40.08 | -25.14% | 3 | Jun 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $50 | $69.93 | -28.50% | 1 | Jun 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $31 → $29 | $11.14 | +160.32% | 2 | May 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $2.10 | +376.19% | 1 | Apr 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $95 → $86 | $73.57 | +16.90% | 2 | Mar 23, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $75 | $4.64 | +1,516.38% | 1 | Mar 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $35 → $44 | $11.90 | +269.75% | 2 | Jan 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $182 → $166 | $24.22 | +585.38% | 1 | Jan 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $18 | $3.09 | +482.52% | 1 | May 5, 2020 |
Genelux
Oct 21, 2025
Initiates: Buy
Price Target: $16
Current: $7.64
Upside: +109.42%
Monopar Therapeutics
Sep 23, 2025
Initiates: Buy
Price Target: $106
Current: $79.92
Upside: +32.63%
Bolt Biotherapeutics
Aug 15, 2025
Maintains: Buy
Price Target: $4 → $75
Current: $5.72
Upside: +1,211.19%
Oncolytics Biotech
Aug 13, 2025
Initiates: Buy
Price Target: $7
Current: $1.22
Upside: +473.77%
Coya Therapeutics
Jul 9, 2025
Initiates: Buy
Price Target: $16
Current: $6.66
Upside: +140.24%
Lantern Pharma
Apr 2, 2025
Initiates: Buy
Price Target: $25
Current: $3.98
Upside: +528.14%
Immunome
Apr 2, 2025
Initiates: Buy
Price Target: $23
Current: $16.39
Upside: +40.33%
OS Therapies
Apr 2, 2025
Initiates: Buy
Price Target: $19
Current: $1.87
Upside: +916.04%
Esperion Therapeutics
Aug 3, 2021
Maintains: Strong Buy
Price Target: $134 → $114
Current: $3.04
Upside: +3,650.00%
Celcuity
Jul 27, 2021
Initiates: Buy
Price Target: $50
Current: $74.44
Upside: -32.83%
Jul 19, 2021
Maintains: Buy
Price Target: $33 → $48
Current: $61.97
Upside: -22.54%
Jun 28, 2021
Maintains: Buy
Price Target: $33 → $30
Current: $40.08
Upside: -25.14%
Jun 17, 2021
Initiates: Buy
Price Target: $50
Current: $69.93
Upside: -28.50%
May 14, 2021
Maintains: Buy
Price Target: $31 → $29
Current: $11.14
Upside: +160.32%
Apr 5, 2021
Initiates: Buy
Price Target: $10
Current: $2.10
Upside: +376.19%
Mar 23, 2021
Maintains: Buy
Price Target: $95 → $86
Current: $73.57
Upside: +16.90%
Mar 15, 2021
Initiates: Buy
Price Target: $75
Current: $4.64
Upside: +1,516.38%
Jan 8, 2021
Maintains: Buy
Price Target: $35 → $44
Current: $11.90
Upside: +269.75%
Jan 8, 2021
Maintains: Buy
Price Target: $182 → $166
Current: $24.22
Upside: +585.38%
May 5, 2020
Maintains: Buy
Price Target: $15 → $18
Current: $3.09
Upside: +482.52%